← All stocks

Corbus Pharmaceuticals Holdings, Inc.

CRBP Net buying
CIK 0001595097 #3966 in the set updated 17 Sep 2026
Bought (120 mo)
$54.96M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.94M
$643.17K on a plan · $4.81M straight out of an exercise
Sold at will
$490.31K
6 of 37 sales
Net
+$49.02M
+$54.47M against sales at will

By person

22 insiders · 140 transactions
1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
10% owner
$53.69M (31)
$344.01K (1)
+$53.35M
2,344,971
12.12%
$18.39M
+430.1%
Cohen Yuval
Chief Executive Officer
$122.23K (15)
$3.76M (13) scheduled
−$3.64M
157,316
0.8134%
$1.23M
Moran Sean F.
Chief Financial Officer
$144.20K (12)
$1.54M (11) scheduled
−$1.40M
84,694
0.4379%
$664.13K
Hochman David P
Director
$269.18K (7)
+$269.18K
814,400
4.21%
$6.39M
+5.9%
White Barbara
Chief Medical Officer
$254.36K (12)
+$254.36K
206,217
1.07%
$1.62M
+28.0%
Saxena Nishant C
Chief Business Officer
$126.25K (3)
+$126.25K
77,900
0.4028%
$610.85K
+2,126%
Smethurst Dominic
Chief Medical Officer
$120.51K (3)
−$120.51K
89,790
0.4642%
$704.09K
Discordia Robert Paul
Chief Operating Officer
$109.51K (3)
+$109.51K
35,490
0.1835%
$278.29K
+134.3%
Panayiotopoulos Paris
Director
$100.39K (1)
+$100.39K
14,285
0.0739%
$112.02K
Millian Craig Stuart
Chief Operating Officer
$76.55K (8)
+$76.55K
27,000
0.1396%
$211.72K
Jenkins John Kenneth
Director
$6.98K (1)
$58.45K (2) scheduled
−$51.47K
3,833
0.0198%
$30.06K
Altmeyer Anne
Director
$50.91K (3) scheduled
−$50.91K
7,579
0.0392%
$59.43K
CATLIN AVERY W
Director
$45.84K (2)
+$45.84K
4,350
0.0225%
$34.11K
Hodgson Ian
Chief Operating Officer
$25.79K (2)
−$25.79K
51,080
0.2641%
$400.54K
+96.6%
Kung Winston
Director
$16.03K (1) scheduled
−$16.03K
12,140
0.0628%
$95.20K
Ben Yong
Director
$15.68K (1) scheduled
−$15.68K
9,383
0.0485%
$73.58K
HOLMER ALAN F
Director
$10.61K (2)
+$10.61K
10,629
0.0550%
$83.35K
Tepper Mark
President and CSO
2,110,400
10.91%
$16.55M
+0.5%
Nicacio Leonardo Viana
Chief Medical Officer
58,333
0.3016%
$457.42K
Jacques Rachelle Suzanne
Director
11,383
0.0589%
$89.26K
Pfeiffenberger Brent
Director
7,500
0.0388%
$58.81K
Salzmann Peter
Director
2,783
0.0144%
$21.82K
Insider
Date
Role
Action
Shares
Price
Amount
Cohen Yuval
27 Oct 2025
Chief Executive Officer
Sold after exercise
8,973
$17.14
$153.80K
Moran Sean F.
24 Oct 2025
Chief Financial Officer
Sold after exercise
12,981
$17.02
$220.94K
Cohen Yuval
24 Oct 2025
Chief Executive Officer
Sold after exercise
18,660
$17.01
$317.41K
Altmeyer Anne
20 Oct 2025
Director
Sold after exercise
1,060
$20.50
$21.73K
Cohen Yuval
18 Jun 2024
Chief Executive Officer
Sold after exercise
7,179
$42.24
$303.22K
Cohen Yuval
18 Jun 2024
Chief Executive Officer
Sold after exercise
2,322
$42.24
$98.07K
Cohen Yuval
18 Jun 2024
Chief Executive Officer
Sold after exercise
1,770
$42.24
$74.76K
Cohen Yuval
18 Jun 2024
Chief Executive Officer
Sold after exercise
11,667
$42.24
$492.78K
Moran Sean F.
18 Jun 2024
Chief Financial Officer
Sold after exercise
1,958
$42.12
$82.48K
Cohen Yuval
17 Jun 2024
Chief Executive Officer
Sold after exercise
1,770
$46.02
$81.46K
Cohen Yuval
17 Jun 2024
Chief Executive Officer
Sold after exercise
9,333
$46.02
$429.51K
Moran Sean F.
17 Jun 2024
Chief Financial Officer
Sold after exercise
6,730
$46.77
$314.79K
Cohen Yuval
14 Jun 2024
Chief Executive Officer
Sold after exercise
12,487
$50.17
$626.43K
Cohen Yuval
14 Jun 2024
Chief Executive Officer
Sold after exercise
16,830
$50.17
$844.30K
Moran Sean F.
14 Jun 2024
Chief Financial Officer
Sold after exercise
7,788
$49.87
$388.42K
Moran Sean F.
14 Jun 2024
Chief Financial Officer
Sold after exercise
1,567
$49.87
$78.15K
Moran Sean F.
21 Dec 2020
Chief Financial Officer
Sold after exercise
87,500
$1.75
$153.13K
Moran Sean F.
18 Dec 2020
Chief Financial Officer
Sold after exercise
53,610
$1.40
$75.05K
Moran Sean F.
16 Dec 2020
Chief Financial Officer
Sold after exercise
36,923
$1.32
$48.63K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 19
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 1,398,906
History held since 8 Sep 2016